Details of the Drug

General Information of Drug (ID: DMSX3A5)

Drug Name

Dendritic cell-based exosome vaccine

Indication

Disease Entry	ICD 11	Status	REF
Lung cancer	2C25.0	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med. 2005 Mar 2;3(1):10.